FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Shibata

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Polina Khrizman; Dana Milne; Joyce C Niland; Deborah Schrag; Stephen Shibata; John M Skibber; A ter Veer; Martin R Weiser; Kelli Bullard Dunn; William E Carson; Paul F Engstrom; Al B Benson
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.
Ari VanderWalde; J Wong; W Ye; Przemyslaw Twardowski; D Asuncion; James Doroshow; Stephen Forman; Paul Frankel; Marianna Koczywas; Lucille Leong; T Luu; Kim Margolin; Robert Morgan; I B Paz; Richard D Pezner; Stephen Shibata; George Somlo
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
Joseph Chao; Vincent Chung; Angela Davies; Igor Espinoza-Delgado; David R Gandara; Barbara J Gitlitz; Charles Kunos; Derick H Lau; Heinz-Josef Lenz; Dean Lim; Jeff Longmate; Mark McNamara; Robert J Morgan; Edward M Newman; Suresh S Ramalingam; Stephen Shibata; Ronald G Stoller; Timothy W Synold; Chandra P Belani; Yun Yen
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Shibata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Polina Khrizman; Dana Milne; Joyce C Niland; Deborah Schrag; Stephen Shibata; John M Skibber; A ter Veer; Martin R Weiser; Kelli Bullard Dunn; William E Carson; Paul F Engstrom; Al B Benson
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):30-8.
2012: Ari VanderWalde; J Wong; W Ye; Przemyslaw Twardowski; D Asuncion; James Doroshow; Stephen Forman; Paul Frankel; Marianna Koczywas; Lucille Leong; T Luu; Kim Margolin; Robert Morgan; I B Paz; Richard D Pezner; Stephen Shibata; George Somlo
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(8):1273-80.
2012: Joseph Chao; Vincent Chung; Angela Davies; Igor Espinoza-Delgado; David R Gandara; Barbara J Gitlitz; Charles Kunos; Derick H Lau; Heinz-Josef Lenz; Dean Lim; Jeff Longmate; Mark McNamara; Robert J Morgan; Edward M Newman; Suresh S Ramalingam; Stephen Shibata; Ronald G Stoller; Timothy W Synold; Chandra P Belani; Yun Yen
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.
Cancer chemotherapy and pharmacology 2012;69(3):835-43.
2012: J Portnow; Karen Reckamp; Stephen Shibata; Przemyslaw Twardowski; Warren Chow; V Chung; M Cristea; Paul Frankel; S Koehler; Lucille Leong; Dean Lim; C Martel; R Morgan; Timothy W Synold
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;69(2):505-14.
2010: Robert J Morgan; Timothy W Synold; Adam N Mamelak; Dean Lim; Zaid Al-Kadhimi; Przemyslaw Twardowski; Lucille Leong; Warren Chow; Kim Margolin; Stephen Shibata; George Somlo; Yun Yen; Paul Frankel; James Doroshow
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.
Cancer chemotherapy and pharmacology 2010;66(5):927-33.
2009: Yi-Jen Chen; Richard D Pezner; David D Smith; Kemp H Kernstine; Dean Lim; An Liu; Stephen Shibata; Martin Tang; Jeffrey Y C Wong
Image-guided Radiotherapy Of Esophageal Cancer By Helical Tomotherapy: Acute Toxicity And Preliminary Clinical Outcome.
Journal of thoracic disease 2009;1(1):11-6.
2009: Solomon Jo; Agnes Juhasz; Keqiang Zhang; Christopher Ruel; Sofia Loera; Sharon P Wilczynski; Yun Yen; Xiyong Liu; Joshua D I Ellenhorn; Dean Lim; Benjamin Paz; George Somlo; Nayana L Vora; Stephen Shibata
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
Anticancer research 2009;29(5):1467-74.
2009: Stephen Shibata; Andrew Raubitschek; Lucille Leong; Marianna Koczywas; Lawrence Williams; Jiping Zhan; Jeffrey Y C Wong
A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2935-41.
2008: Thomas Lowe; Thehang Luu; Jeannie Shen; Smita Bhatia; Stephen Shibata; Anthony Stein; George Somlo
Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia.
Onkologie 2008;31(5):266-9.
2007: Yi-Jen Chen; Chunhui Han; An Liu; Timothy Schultheiss; Kemp H Kernstine; Stephen Shibata; Nayana L Vora; Richard D Pezner; Jeffrey Y C Wong
Setup variations in radiotherapy of esophageal cancer: evaluation by daily megavoltage computed tomographic localization.
International journal of radiation oncology, biology, physics 2007;68(5):1537-45.
2007: Robert J Morgan; Timothy W Synold; David R Gandara; Franco Muggia; Sidney Scudder; E Reed; Kim Margolin; James Raschko; Lucille Leong; Stephen Shibata; Merry Tetef; Steven Vasilev; Kathryn F McGonigle; Jeff Longmate; Yun Yen; Warren Chow; George Somlo; Mary Carroll; James Doroshow
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(2):373-8.
2007: Stephen Shibata; Warren Chow; Paul Frankel; Agnes Juhasz; Lucille Leong; Dean Lim; Kim Margolin; Robert Morgan; Edward Newman; George Somlo; Yun Yen; Timothy W Synold; David R Gandara; Heinz-Josef Lenz; James Doroshow
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression.
Cancer chemotherapy and pharmacology 2007;59(4):549-57.
2007: Robert J Morgan; Timothy W Synold; Bixin Xi; Dean Lim; Stephen Shibata; Kim Margolin; Roderich E Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Merry Tetef; Paul Lin; Benjamin Paz; Mariana Koczywas; Lawrence D Wagman; David Chu; Paul Frankel; Susan Stalter; James Doroshow
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1232-7.
2007: Yi-Jen Chen; An Liu; Chunhui Han; Peter T Tsai; Timothy Schultheiss; Richard D Pezner; Nayana L Vora; Dean Lim; Stephen Shibata; Kemp H Kernstine; Jeffrey Y C Wong
Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2007;32(3):166-71.
2005: Kim Margolin; James Doroshow; Paul Frankel; Warren Chow; Lucille A Leong; Dean Lim; Mark McNamara; Robert J Morgan; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; Neil Kogut; Jeffrey Schriber; Joseph Alvarnas; Susan Stalter
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):903-11.
2004: Robert J Morgan; Timothy W Synold; David R Gandara; Franco Muggia; Sidney Scudder; Eddie Reed; Kim Margolin; James Raschko; Lucille Leong; Stephen Shibata; Merry Tetef; Steven Vasilev; Kathryn F McGonigle; Jeff Longmate; Yun Yen; Warren Chow; George Somlo; Mary Carroll; James Doroshow
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
Cancer chemotherapy and pharmacology 2004;54(4):283-9.
2004: Warren A Chow; Timothy W Synold; Merry Tetef; Jeff Longmate; Paul Frankel; Joyce Lawrence; Zaid Al-Khadimi; Lucille Leong; Dean Lim; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; James Doroshow
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Cancer chemotherapy and pharmacology 2004;54(3):241-8.
2004: Stephen Shibata; Richard D Pezner; David Chu; James Doroshow; Warren A Chow; Lucille A Leong; Kim Margolin; Mark McNamara; Robert J Morgan; James Raschko; George Somlo; Merry Tetef; Yun Yen; Timothy W Synold; Lawrence D Wagman; Nayana L Vora; Mary Carroll; S Lin; Jeff Longmate
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2004;30(6):650-7.
2004: George Somlo; Paul Frankel; Warren Chow; Lucille Leong; Kim Margolin; Robert Morgan; Stephen Shibata; Peiguo Chu; Stephen Forman; Dean Lim; Przemyslaw Twardowski; Jeffrey N Weitzel; Joseph Alvarnas; Neil Kogut; Jeffrey Schriber; Eleanor Fermin; Yun Yen; Lloyd Damon; James Doroshow
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1839-48.
2004: Harry Openshaw; Karen Beamon; Timothy W Synold; Jeff Longmate; Neal E Slatkin; James Doroshow; Stephen Forman; Kim Margolin; Robert Morgan; Stephen Shibata; George Somlo
Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):461-7.
2003: Robert J Morgan; James Doroshow; Timothy W Synold; Dean Lim; Stephen Shibata; Kim Margolin; Roderich Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Paul Lin; Benjamin Paz; David Chu; Paul Frankel; Susan Stalter
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5896-901.
2003: Jeffrey Y C Wong; Stephen Shibata; Lawrence E Williams; Cheuk S Kwok; An Liu; David Z J Chu; Dave M Yamauchi; Sharon P Wilczynski; David Ikle; Anna M Wu; Paul J Yazaki; John E Shively; James Doroshow; Andrew Raubitschek
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5842-52.
2002: Yun Yen; Warren Chow; Lucille Leong; Kim Margolin; Robert Morgan; James Raschko; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Paul Frankel; Jeff Longmate; Timothy W Synold; Edward M Newman; Heinz-Josef Lenz; David R Gandara; James Doroshow
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial.
Cancer chemotherapy and pharmacology 2002;50(5):353-9.
2002: George Somlo; J F Simpson; Paul Frankel; Warren Chow; Lucille Leong; Kim Margolin; Robert Morgan; James Raschko; Stephen Shibata; Stephen Forman; Neil Kogut; Mark McNamara; Arturo Molina; E Somlo; James Doroshow
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.
British journal of cancer 2002;87(3):281-8.
2001: Robert J Morgan; James Doroshow; Lucille Leong; Jeffrey Schriber; Stephen Shibata; Stephen Forman; Victor Hamasaki; Kim Margolin; George Somlo; Joseph Alvarnas; Mark McNamara; Jeff Longmate; James Raschko; Warren Chow; Steven Vasilev; Kathryn F McGonigle; Yun Yen
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
Bone marrow transplantation 2001;28(9):859-63.
2001: George Somlo; James Doroshow; Timothy W Synold; Jeff Longmate; D Reardon; Warren Chow; Stephen J Forman; Lucille A Leong; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; Merry Tetef; Yun Yen; Neil Kogut; Jeffrey Schriber; Joseph Alvarnas
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
British journal of cancer 2001;84(12):1591-8.
2001: Merry Tetef; Timothy W Synold; Warren Chow; Lucille Leong; Kim Margolin; Robert Morgan; James Raschko; Stephen Shibata; George Somlo; Yun Yen; S Groshen; K Johnson; Heinz-Josef Lenz; David R Gandara; James Doroshow
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1569-76.
2001: Robert J Morgan; Timothy W Synold; B I Carr; James Doroshow; E P Womack; Stephen Shibata; George Somlo; James Raschko; Lucille Leong; Mark McNamara; Warren Chow; Merry Tetef; Kim Margolin; Steven Akman; Jeff Longmate
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy.
Cancer chemotherapy and pharmacology 2001;47(4):327-32.
2001: George Somlo; Warren Chow; Victor Hamasaki; Lucille Leong; Kim Margolin; Robert Morgan; Irena Sniecinski; Paul Frankel; D Reardon; E Longmate; James Raschko; Stephen Shibata; Margaret O'Donnell; Eileen Smith; Merry Tetef; Stephen Forman; Yun Yen; Arturo Molina; H Doroshow
Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(5):284-93.
2000: Robert J Morgan; P Braly; Lucille Leong; Stephen Shibata; Kim Margolin; George Somlo; Mark McNamara; Jeff Longmate; S Schinke; James Raschko; S Nagasawa; Neil Kogut; L Najera; D Johnson; James Doroshow
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Gynecologic oncology 2000;77(3):433-8.
2000: James Raschko; Timothy W Synold; Warren Chow; PH Coluzzi; Victor Hamasaki; Lucille A Leong; Kim Margolin; Robert J Morgan; Stephen Shibata; George Somlo; Merry Tetef; Yun Yen; A ter Veer; James Doroshow
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.
Cancer chemotherapy and pharmacology 2000;46(5):403-10.
1999: Robert J Morgan; P Braly; G Cecchi; Lucille Leong; Stephen Shibata; Kim Margolin; George Somlo; Mark McNamara; Jeff Longmate; S Schinke; James Raschko; S Nagasawa; Neil Kogut; Pablo Parker; Anthony Stein; J Cho; E Smith; PH Coluzzi; L Najera; D Johnson; E Womack; James Doroshow
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Gynecologic oncology 1999;75(3):419-26.
1999: George Somlo; Irena Sniecinski; A ter Veer; Jeff Longmate; Gaylord J Knutson; S Vuk-Pavlovic; Ravi Bhatia; Warren Chow; Lucille Leong; Robert Morgan; Kim Margolin; James Raschko; Stephen Shibata; Merry Tetef; Yun Yen; Stephen Forman; Denny Jones; Mark Ashby; Gwen Fyfe; Sue Hellmann; James Doroshow
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.
Blood 1999;93(9):2798-806.
1999: Merry Tetef; Lucille Leong; Chul Ahn; Steven Akman; Warren Chow; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; James Doroshow
Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial.
Cancer investigation 1999;17(2):114-7.
1999: Richard D Pezner; David Z J Chu; Lawrence D Wagman; Nayana L Vora; Jeffrey Y C Wong; Stephen Shibata
Resection with external beam and intraoperative radiotherapy for recurrent colon cancer.
Archives of surgery (Chicago, Ill. : 1960) 1999;134(1):63-7.
1998: Robert J Morgan; Edward M Newman; James Doroshow; Kathryn F McGonigle; Kim Margolin; James Raschko; Warren Chow; George Somlo; Lucille Leong; Merry Tetef; Stephen Shibata; Victor Hamasaki; Mary Carroll; Steven Vasilev; Steven Akman; PH Coluzzi; Lawrence D Wagman; Jeff Longmate; Benjamin Paz; Yun Yen; Robert R Klevecz
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Cancer research 1998;58(13):2793-800.
1997: Robert J Morgan; James Doroshow; K Venkataraman; K Chang; James Raschko; George Somlo; Lucille Leong; Merry Tetef; Stephen Shibata; Victor Hamasaki; Kim Margolin; Stephen Forman; Steven Akman; PH Coluzzi; Chul Ahn; L Weiss; U Gadgil; J Harrison
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2337-45.
1997: George Somlo; James Doroshow; Stephen J Forman; TL Odom-Maryon; J Lee; Warren Chow; Victor Hamasaki; Lucille Leong; Robert Morgan; Kim Margolin; James Raschko; Stephen Shibata; Merry Tetef; Yun Yen; J Simpson; Arturo Molina
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2882-93.
1997: George Somlo; Irena Sniecinski; TL Odom-Maryon; B Nowicki; Warren Chow; Victor Hamasaki; Lucille Leong; Kim Margolin; Robert Morgan; James Raschko; Stephen Shibata; Merry Tetef; Arturo Molina; R J Berenson; Stephen J Forman; James Doroshow
Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer.
Blood 1997;89(5):1521-8.
1997: Edward M Newman; Mary Carroll; Steven Akman; Warren Chow; PH Coluzzi; Victor Hamasaki; Lucille A Leong; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; Merry Tetef; Yun Yen; Chul Ahn; James Doroshow
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 1997;39(3):254-8.
1996: Kim Margolin; James Doroshow; Chul Ahn; Victor Hamasaki; Lucille Leong; Robert Morgan; James Raschko; Stephen Shibata; George Somlo; Merry Tetef
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2631-7.
1995: Merry Tetef; Kim Margolin; Chul Ahn; Steven Akman; Warren Chow; PH Coluzzi; Lucille Leong; Robert J Morgan; James Raschko; Stephen Shibata
Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial.
Journal of cancer research and clinical oncology 1995;121(2):103-6.
1995: Merry Tetef; James Doroshow; Steven Akman; PH Coluzzi; Lucille Leong; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo
5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.
Cancer investigation 1995;13(5):460-3.